About Mark
Mr. Kovner represents clients in complex government antitrust investigations and litigations. He has cleared hundreds of challenging transactions through the HSR process, expeditiously and most often without the need for any remedies.Named a “National Litigation Star” for antitrust by Benchmark Litigation (2008–2020), Mark is consistently recognized as one of the country’s leading antitrust practitioners by Chambers & Partners USA; The Best Lawyers in America; Washington, D.C., Super Lawyers, and The International Who’s Who of Competition Lawyers and Economists. Legal Media Group’s Expert Guide “Best of the Best USA 2013” named Mark one of the 30 best lawyers in US antitrust. He has an “AV Preeminent” rating from Martindale Hubbell.Global Competition Review awarded the complex Teva Pharmaceuticals/Allergan merger clearance, handled by Mr. Kovner and the Kirkland team, as its 2016 Merger Control Matter of the Year - Americas.Mr. Kovner was an Adjunct Professor at Georgetown University Law Center for 19 years, from 2001 through 2019, where he taught Antitrust Law. He is currently the President of the Board of Directors of the Washington Council of Lawyers, a Washington, D.C., pro bono bar association with over 550 members.Legal 500 U.S. gives Kirkland a Tier 1 ranking for “Mergers, Acquisitions and Buyouts: Antitrust,” and Kirkland’s antitrust practice has a Tier 1 ranking in U.S. News & World Report’s “Best Law Firms.” Kirkland’s antitrust practice was named a Law360 Competition Group of the Year in 2014 and 2012.
Mr. Kovner represents clients in complex government antitrust investigations and litigations. He has cleared hundreds of challenging transactions through the HSR process, expeditiously and most often without the need for any remedies.Named a “National Litigation Star” for antitrust by Benchmark Litigation (2008–2020), Mark is consistently recognized as one of the country’s leading antitrust practitioners by Chambers & Partners USA; The Best Lawyers in America; Washington, D.C., Super Lawyers, and The International Who’s Who of Competition Lawyers and Economists. Legal Media Group’s Expert Guide “Best of the Best USA 2013” named Mark one of the 30 best lawyers in US antitrust. He has an “AV Preeminent” rating from Martindale Hubbell.Global Competition Review awarded the complex Teva Pharmaceuticals/Allergan merger clearance, handled by Mr. Kovner and the Kirkland team, as its 2016 Merger Control Matter of the Year - Americas.Mr. Kovner was an Adjunct Professor at Georgetown University Law Center for 19 years, from 2001 through 2019, where he taught Antitrust Law. He is currently the President of the Board of Directors of the Washington Council of Lawyers, a Washington, D.C., pro bono bar association with over 550 members.Legal 500 U.S. gives Kirkland a Tier 1 ranking for “Mergers, Acquisitions and Buyouts: Antitrust,” and Kirkland’s antitrust practice has a Tier 1 ranking in U.S. News & World Report’s “Best Law Firms.” Kirkland’s antitrust practice was named a Law360 Competition Group of the Year in 2014 and 2012.
Mr. Kovner represents clients in complex government antitrust investigations and litigations. He has cleared hundreds of challenging transactions through the HSR process, expeditiously and most often without the need for any remedies.
Named a “National Litigation Star” for antitrust by Benchmark Litigation (2008–2020), Mark is consistently recognized as one of the country’s leading antitrust practitioners by Chambers & Partners USA; The Best Lawyers in America; Washington, D.C., Super Lawyers, and The International Who’s Who of Competition Lawyers and Economists. Legal Media Group’s Expert Guide “Best of the Best USA 2013” named Mark one of the 30 best lawyers in US antitrust. He has an “AV Preeminent” rating from Martindale Hubbell.
Global Competition Review awarded the complex Teva Pharmaceuticals/Allergan merger clearance, handled by Mr. Kovner and the Kirkland team, as its 2016 Merger Control Matter of the Year - Americas.
Mr. Kovner was an Adjunct Professor at Georgetown University Law Center for 19 years, from 2001 through 2019, where he taught Antitrust Law. He is currently the President of the Board of Directors of the Washington Council of Lawyers, a Washington, D.C., pro bono bar association with over 550 members.
Legal 500 U.S. gives Kirkland a Tier 1 ranking for “Mergers, Acquisitions and Buyouts: Antitrust,” and Kirkland’s antitrust practice has a Tier 1 ranking in U.S. News & World Report’s “Best Law Firms.” Kirkland’s antitrust practice was named a Law360 Competition Group of the Year in 2014 and 2012.
Mr. Kovner represents clients in complex government antitrust investigations and litigations. He has cleared hundreds of challenging transactions through the HSR process, expeditiously and most often without the need for any remedies.Named a “National Litigation Star” for antitrust by Benchmark Litigation (2008–2020), Mark is consistently recognized as one of the country’s leading antitrust practitioners by Chambers & Partners USA; The Best Lawyers in America; Washington, D.C., Super Lawyers, and The International Who’s Who of Competition Lawyers and Economists. Legal Media Group’s Expert Guide “Best of the Best USA 2013” named Mark one of the 30 best lawyers in US antitrust. He has an “AV Preeminent” rating from Martindale Hubbell.Global Competition Review awarded the complex Teva Pharmaceuticals/Allergan merger clearance, handled by Mr. Kovner and the Kirkland team, as its 2016 Merger Control Matter of the Year - Americas.Mr. Kovner was an Adjunct Professor at Georgetown University Law Center for 19 years, from 2001 through 2019, where he taught Antitrust Law. He is currently the President of the Board of Directors of the Washington Council of Lawyers, a Washington, D.C., pro bono bar association with over 550 members.Legal 500 U.S. gives Kirkland a Tier 1 ranking for “Mergers, Acquisitions and Buyouts: Antitrust,” and Kirkland’s antitrust practice has a Tier 1 ranking in U.S. News & World Report’s “Best Law Firms.” Kirkland’s antitrust practice was named a Law360 Competition Group of the Year in 2014 and 2012.
Mr. Kovner represents clients in complex government antitrust investigations and litigations. He has cleared hundreds of challenging transactions through the HSR process, expeditiously and most often without the need for any remedies.
Named a “National Litigation Star” for antitrust by Benchmark Litigation (2008–2020), Mark is consistently recognized as one of the country’s leading antitrust practitioners by Chambers & Partners USA; The Best Lawyers in America; Washington, D.C., Super Lawyers, and The International Who’s Who of Competition Lawyers and Economists. Legal Media Group’s Expert Guide “Best of the Best USA 2013” named Mark one of the 30 best lawyers in US antitrust. He has an “AV Preeminent” rating from Martindale Hubbell.
Global Competition Review awarded the complex Teva Pharmaceuticals/Allergan merger clearance, handled by Mr. Kovner and the Kirkland team, as its 2016 Merger Control Matter of the Year - Americas.
Mr. Kovner was an Adjunct Professor at Georgetown University Law Center for 19 years, from 2001 through 2019, where he taught Antitrust Law. He is currently the President of the Board of Directors of the Washington Council of Lawyers, a Washington, D.C., pro bono bar association with over 550 members.
Legal 500 U.S. gives Kirkland a Tier 1 ranking for “Mergers, Acquisitions and Buyouts: Antitrust,” and Kirkland’s antitrust practice has a Tier 1 ranking in U.S. News & World Report’s “Best Law Firms.” Kirkland’s antitrust practice was named a Law360 Competition Group of the Year in 2014 and 2012.
